MaxCyte Inc (MXCT)
US$ 2.252.27%
Price Chart
Key Statistics
Market Cap
$ 236.24M
P/E Ratio
0.00
Revenue (TTM)
$ 37.68M
Volume
1.48M
52W High
$ 5.20
52W Low
$ 2.00
Dividend Yield
0.00%
Beta
0.30
Technicals
50-Day MA
2.3011
200-Day MA
3.3483
52 Week High
5.2
52 Week Low
2
About MXCT
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
Employees
114
Headquarters
Rockville, MD
CEO
Mr. Maher Masoud
Latest News
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - TradingView
2 days ago • Google News
Down -27.78% in 4 Weeks, Here's Why You Should You Buy the Dip in MaxCyte (MXCT) - Yahoo Finance
2025-04-08 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg